Exclusive patent and know-how license to develop, use, sell, offer for sale, have sold, import, export, commercialize and sublicense, with nonexclusive rights to manufacture pharmaceutical products containing the D-63153 compound, which is a LHRH antagonist, as an active ingredient alone or as combination-preparations, for all human uses, including for oncology, such as benign hyperplasia, prostate cancer, and related endometriosis.